FDA Inspection 1312624 — Jonathan W. Goldman, MD
The FDA completed an inspection of Jonathan W. Goldman, MD on Apr 9, 2026 in Santa Monica, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 9, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Santa Monica, CA (United States)
Additional Details
Clinical Investigator (CI)